Monog.M'd.- 12 CASTELLË filmar2 - Acadèmia

274 UNIDADES DEL DOLOR. REALIDAD HOY, RETO PARA EL FUTUROBIBLIOGRAFÍA.Asano M, Inamura N, Hatori C, Sawai H, Fujiwara T, Katayama A, et al. Theidentification of an orally active, nonpeptide bradykinin B 2 receptor antagonist,FR 173657. Br J Pharmacol 1997; 120: 617-624.Badio B, Daly JW. Epibatidine, a potent analgesic and nicotinic agonist. MolPharmacol 1994; 45: 563-569.Barinaga M. How cannabinoids work in the brain. Science 2001; 291:2530-2531.Belfrage M, Sollevi A, Segerdahl M, Sjölund K-F, Hanson P. Systemic adenosineinfusion alleviates spontaneous and stimulus evoked pain in patients with periphericneuropathic pain. Anest Analg 1995; 81: 713-717.Bleehen T, Hobbiger F, Keele CA. Identification of algogenic substances in humanerythrocytes. J Physiol 1976; 262: 131-149.Bridges D, Ahmad K, Rice ASC. The synthetic cannabinoid WIN55,212-2 attenuateshyperalgesia and allodynia in a rat model of neuropathic pain. Br JPharmacol 2001; 33: 586-594.Burnstock G. Purine-mediated signalling in pain and visceral perception. TiPS2001; 22: 182-188.Burnstock G, Wood JN. Purinergic receptors: their role in nociception and primaryafferent neurotransmission. Curr Opinion Neurobiol 1996; 6: 526-532.Campbell FA, Tramer MR, Carroll D, Reynolds JM, Moore RA, McQuay HJ. Arecannabinoids an effective and safe treatment option in the management of pain?A qualitative systematic review. BMJ 2001; 323:13-16.Carlton SM, Hargett GL, Coggeshall RE. Localization and activation of glutamatereceptors in unmyelinated axons of rat glabrous skin. Neurosci Lett 1995;197:25-28.Caterina MJ, Schumacher MA, Tominga M, Rosen TA, Levine JD, Julius D. Thecapsaicin receptor: a heat-activated ion channel in the pain pathway. Nature1997; 389: 816-824.Caterina MJ, Leffler A, Malmberg AB, Martín WJ, Trafton J, Petersen-Zeitz KF,Koltzenburg M, Basbaum AI, Julius D. Impaired nociception and pain sensationin mice lacking the capsaicin receptor. Science 2000; 288:241-242.Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D. A capsaicin-receptorhomologue with a high threshold for noxius heat. Nature 1999; 398: 436-441.Cerveró F, Laird JMA. One pain or many pains?: a new look at pain mechanisms.NIPS 1991; 6: 268-273.Chapman V, Dickenson AH. Time-related roles of excitatory amino acid receptorsduring persistent noxiously evoked responses of rat dorsal horn neurones. BrainRes 1995; 703: 45-40.Chast F. Histoire contemporaine des médicaments. Editions La Découverte: Paris, 1995.Coderre TJ. Excitatory amino acid antagonists: potential analgesics for persistenpain. En Sawynok J, Cowan A (eds.) Novel aspects of pain management. Opioidsand beyond. John Wiley & Sons: Nueva York, 1999; 157-178.Coderre TJ, Van Empel I. The utility of excitatory amino acid (EAA) antagonistsas analgesic agents. II. Assessment of the antinociceptive activity of combinationsof competitive and non-competitive NMDA antagonists with agents acting atallosteric-glycine and polyamine receptor sites. Pain 1994; 59: 353-359.